About REVATIO® (sildenafil) | Safety Info

Why Revatio

For almost 15 years, brand-name REVATIO has helped treat pulmonary arterial hypertension (PAH) in adults. If you have PAH, ask your doctor about moving forward with brand-name REVATIO.

REVATIO is clinically proven

  • In a clinical study of 267 PAH patients, REVATIO taken with epoprostenol:

  • Increased the distance people walked in a 6-minute defined time

  • Decreased pressure in the pulmonary artery

  • Helped lessen symptoms of PAH§

  • Helped slow down worsening changes in physical condition||

All patients continued intravenous epoprostenol therapy.

Patients on REVATIO achieved a statistically important reduction in mPAP vs placebo.

§Measured by improvements in WHO functional class (classifies patients based on limitations of physical activity and symptoms).

||REVATIO patients had a significant delay to clinical worsening and were less likely to experience clinical worsening (death, lung transplantation, initiation of bosentan, or clinical deterioration) vs placebo.

Revatio is the brand you recognize

  • The REVATIO pill has a distinctive shape and marking to let you know you're getting the brand-name medication—pill to pill, month to month

  • If your pill does not say RVT 20, and you want brand-name REVATIO, talk to your pharmacist

Revatio Pills

Revatio Offers Savings To Patients

If eligible, patients may pay as little as $0 each month for brand-name REVATIO—and could save up to $12,000 a year.*


You Are Now Leaving Revatio.com

Links to another site are provided as a convenience to the viewer.

We accept no responsibility for the content of linked sites.


You Are Now Leaving Revatio.com

The information provided in REVATIO.COM/HCP is intended only for healthcare professionals in the United States.